Arterial Aging: The Role of Hormonal and Metabolic Status and Telomere Biology

  • Irina D. StrazheskoEmail author
  • Daria A. Kashtanova
  • Ekaterina N. Dudinskaya
  • Olga N. Tkacheva
Part of the Healthy Ageing and Longevity book series (HAL, volume 10)


Age-associated arterial wall changes create an enzymatically and metabolically favorable environment for cardiovascular diseases development. Understanding the essence of the processes underlying the development of CVD can open up new opportunities for more effective preventive actions. Age, gender, blood pressure, lipid levels, type 2 diabetes mellitus are traditional cardiovascular risk factors used in the most popular models, such as Framingham and SCORE. However, these risk stratification systems have a number of limitations and explain no more than 50% reduction in mortality from cardiovascular diseases. There is not enough information on the association between signs of arterial wall aging and factors that determine the aging processes in general and in their interaction with cardiovascular risk factors. The aim of the work was to study the relationship between parameters of arterial wall aging, traditional risk factors, hormonal status, leukocyte telomere length. A total of 303 ambulatory participants (104 males and 199 females) were recruited. The subjects ranged between 23 and 91 years of age, with a mean age of 51.8 ± 13.3 years. Based on the results obtained, the following conclusions can be drawn: the value of traditional cardiovascular risk factors for the vascular wall changes is reduced in older age; carbohydrate metabolism disorders and hypertension are “universal” risk factors most closely associated with the arterial wall condition in both younger and older group. To predict changes in the vascular wall, it is advisable to study insulin resistance, growth hormone, insulin-like growth factor-1 activity and leukocyte telomere length along with conventional cardiovascular risk factors.


Arterial aging Cardiovascular risk factors Insulin resistance Growth hormone Insulin-like growth factor-1 Leukocyte telomere length Telomerase activity 


  1. Arnqvist HJ (2008) The role of IGF-system in vascular insulin resistance. Horm Metab Res 40(9):588–592PubMedCrossRefPubMedCentralGoogle Scholar
  2. Asvold BO, Vatten LJ, Bjoro T, Bauer DC, Bremner A, Cappola AR et al (2015) Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts. JAMA Intern Med 175(6):1037–1047PubMedPubMedCentralCrossRefGoogle Scholar
  3. Aviv A (2004) Telomeres and human aging: facts and fibs. Sci Aging Knowl Environ 2004(51):pe43PubMedCrossRefPubMedCentralGoogle Scholar
  4. Bano A, Chaker L, Mattace-Raso FUS, van der Lugt A, Ikram MA, Franco OH et al (2017) Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: the Rotterdam Study. Circ Res 121(12):1392–1400PubMedCrossRefPubMedCentralGoogle Scholar
  5. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P et al (2002) Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39(1):10–15PubMedCrossRefPubMedCentralGoogle Scholar
  6. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J et al (2007) Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369(9556):107–114PubMedCrossRefPubMedCentralGoogle Scholar
  7. Brunner EJ, Shipley MJ, Ahmadi-Abhari S, Tabak AG, McEniery CM, Wilkinson IB et al (2015) Adiposity, obesity, and arterial aging: longitudinal study of aortic stiffness in the Whitehall II cohort. Hypertension 66(2):294–300PubMedPubMedCentralCrossRefGoogle Scholar
  8. Calado RT, Young NS (2009) Telomere diseases. N Engl J Med 361(24):2353–2365PubMedPubMedCentralCrossRefGoogle Scholar
  9. Carter CS, Ramsey MM, Ingram RL, Cashion AB, Cefalu WT, Wang ZQ et al (2002) Models of growth hormone and IGF-1 deficiency: applications to studies of aging processes and life-span determination. J Gerontol A Biol Sci Med Sci 57(5):B177–B188PubMedCrossRefPubMedCentralGoogle Scholar
  10. Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30(10):e47PubMedPubMedCentralCrossRefGoogle Scholar
  11. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1115PubMedCrossRefPubMedCentralGoogle Scholar
  12. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G (2001) Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86(2):732–737PubMedCrossRefPubMedCentralGoogle Scholar
  13. Chaker L, Baumgartner C, den Elzen WP, Collet TH, Ikram MA, Blum MR et al (2016) Thyroid function within the reference range and the risk of stroke: an individual participant data analysis. J Clin Endocrinol Metab 101(11):4270–4282PubMedPubMedCentralCrossRefGoogle Scholar
  14. Chiche F, Jublanc C, Coudert M, Carreau V, Kahn JF, Bruckert E (2009) Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients. Atherosclerosis 203(1):269–276PubMedCrossRefPubMedCentralGoogle Scholar
  15. Chisalita SI, Arnqvist HJ (2004) Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. Am J Physiol Endocrinol Metab 286(6):E896–E901PubMedCrossRefPubMedCentralGoogle Scholar
  16. Chisalita SI, Johansson GS, Liefvendahl E, Back K, Arnqvist HJ (2009) Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2. J Mol Endocrinol 43(6):231–239PubMedCrossRefPubMedCentralGoogle Scholar
  17. Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57(1):109–115PubMedCrossRefPubMedCentralGoogle Scholar
  18. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ et al (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166(2):379–386PubMedCrossRefPubMedCentralGoogle Scholar
  19. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24(11):987–1003PubMedCrossRefPubMedCentralGoogle Scholar
  20. Conti E, Andreotti F, Sciahbasi A, Riccardi P, Marra G, Menini E et al (2001) Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J Am Coll Cardiol 38(1):26–32PubMedCrossRefPubMedCentralGoogle Scholar
  21. Cunha PG, Cotter J, Oliveira P, Vila I, Sousa N (2015) An epidemiological study determining blood pressure in a Portuguese cohort: the Guimaraes/Vizela study. J Hum Hypertens 29(3):190–197PubMedCrossRefPubMedCentralGoogle Scholar
  22. D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM et al (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6):743–753PubMedCrossRefPubMedCentralGoogle Scholar
  23. De Sibio MT, Luvizotto RA, Olimpio RM, Correa CR, Marino J, de Oliveira M et al (2013) A comparative genotoxicity study of a supraphysiological dose of triiodothyronine (T(3)) in obese rats subjected to either calorie-restricted diet or hyperthyroidism. PLoS ONE 8(2):e56913PubMedPubMedCentralCrossRefGoogle Scholar
  24. Delitala AP, Orru M, Filigheddu F, Pilia MG, Delitala G, Ganau A et al (2015) Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study. Clin Endocrinol 82(4):592–597CrossRefGoogle Scholar
  25. D’Mello MJ, Ross SA, Briel M, Anand SS, Gerstein H, Pare G (2015) Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis. Circ Cardiovasc Genet. 8(1):82–90PubMedCrossRefPubMedCentralGoogle Scholar
  26. Dorr M, Empen K, Robinson DM, Wallaschofski H, Felix SB, Volzke H (2008) The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area. Eur J Endocrinol 159(2):145–152PubMedCrossRefPubMedCentralGoogle Scholar
  27. Epel ES, Merkin SS, Cawthon R, Blackburn EH, Adler NE, Pletcher MJ et al (2008) The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging 1(1):81–88PubMedPubMedCentralCrossRefGoogle Scholar
  28. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) The fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol 19(4):585–667Google Scholar
  29. Fitzpatrick AL, Kronmal RA, Gardner JP, Psaty BM, Jenny NS, Tracy RP et al (2007) Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 165(1):14–21PubMedCrossRefPubMedCentralGoogle Scholar
  30. Fleg JL, O’Connor F, Gerstenblith G, Becker LC, Clulow J, Schulman SP et al (1995) Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 78(3):890–900PubMedCrossRefGoogle Scholar
  31. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3):356–359PubMedCrossRefGoogle Scholar
  32. Fuster V, Kelly BB, Vedanthan R (2011) Global cardiovascular health: urgent need for an intersectoral approach. J Am Coll Cardiol 58(12):1208–1210PubMedCrossRefGoogle Scholar
  33. Galderisi M, Caso P, Cicala S, De Simone L, Barbieri M, Vitale G et al (2002) Positive association between circulating free insulin-like growth factor-1 levels and coronary flow reserve in arterial systemic hypertension. Am J Hypertens 15(9):766–772PubMedCrossRefGoogle Scholar
  34. Giltay EJ, Lambert J, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD (1999) Arterial compliance and distensibility are modulated by body composition in both men and women but by insulin sensitivity only in women. Diabetologia 42(2):214–221PubMedCrossRefPubMedCentralGoogle Scholar
  35. Gottsater M, Ostling G, Persson M, Engstrom G, Melander O, Nilsson PM (2015) Non-hemodynamic predictors of arterial stiffness after 17 years of follow-up: the Malmo Diet and Cancer study. J Hypertens 33(5):957–965PubMedPubMedCentralCrossRefGoogle Scholar
  36. Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G (2011) Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 57(3):363–369PubMedPubMedCentralCrossRefGoogle Scholar
  37. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P (2014) Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ 349:g4227PubMedPubMedCentralCrossRefGoogle Scholar
  38. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C (1991) Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 134(3):250–256PubMedCrossRefGoogle Scholar
  39. Higashi Y, Sukhanov S, Anwar A, Shai SY, Delafontaine P (2012) Aging, atherosclerosis, and IGF-1. J Gerontol A Biol Sci Med Sci 67(6):626–639PubMedCrossRefGoogle Scholar
  40. Howard G, Manolio TA, Burke GL, Wolfson SK, O’Leary DH (1997) Does the association of risk factors and atherosclerosis change with age? An analysis of the combined ARIC and CHS cohorts. The atherosclerosis risk in communities (ARIC) and cardiovascular health study (CHS) investigators. Stroke 28(9):1693–1701PubMedCrossRefGoogle Scholar
  41. Hu CT, Chang KC, Wu CY, Chen HI (1997) Acute effects of nitric oxide blockade with L-NAME on arterial haemodynamics in the rat. Br J Pharmacol 122(6):1237–1243PubMedPubMedCentralCrossRefGoogle Scholar
  42. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW et al (1997) The recent decline in mortality from coronary heart disease, 1980–1990. The effect of secular trends in risk factors and treatment. JAMA 277(7):535–542PubMedCrossRefGoogle Scholar
  43. Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, Esposito G et al (2001) Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 103(24):2980–2986PubMedCrossRefGoogle Scholar
  44. Jacob MP (2003) Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 57(5–6):195–202PubMedCrossRefGoogle Scholar
  45. Jorde R, Joakimsen O, Stensland E, Mathiesen EB (2008) Lack of significant association between intima-media thickness in the carotid artery and serum TSH level. The Tromso Study. Thyroid 18(1):21–25PubMedCrossRefGoogle Scholar
  46. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T (2002) Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106(8):939–944PubMedCrossRefGoogle Scholar
  47. Kannel WB (2002) Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 11(2):101–107PubMedCrossRefGoogle Scholar
  48. Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K (2004) Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis 173(1):13–18PubMedCrossRefGoogle Scholar
  49. Koivistoinen T, Virtanen M, Hutri-Kahonen N, Lehtimaki T, Jula A, Juonala M et al (2012) Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the cardiovascular risk in Young Finns Study and the Health 2000 Survey. Atherosclerosis 220(2):387–393PubMedCrossRefGoogle Scholar
  50. Konova E, Baydanoff S, Atanasova M, Velkova A (2004) Age-related changes in the glycation of human aortic elastin. Exp Gerontol 39(2):249–254PubMedCrossRefPubMedCentralGoogle Scholar
  51. Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O’Leary D et al (1994) Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 139(12):1164–1179PubMedCrossRefGoogle Scholar
  52. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D (2004) The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 89(1):114–120PubMedCrossRefPubMedCentralGoogle Scholar
  53. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27(21):2588–2605PubMedCrossRefPubMedCentralGoogle Scholar
  54. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16(2):143–163PubMedCrossRefPubMedCentralGoogle Scholar
  55. Li G, Barrett EJ, Ko SH, Cao W, Liu Z (2009) Insulin and insulin-like growth factor-I receptors differentially mediate insulin-stimulated adhesion molecule production by endothelial cells. Endocrinology 150(8):3475–3482PubMedPubMedCentralCrossRefGoogle Scholar
  56. Libby P, Sasiela W (2006) Plaque stabilization: can we turn theory into evidence? Am J Cardiol 98(11A):26P–33PPubMedCrossRefPubMedCentralGoogle Scholar
  57. McEniery CM, Spratt M, Munnery M, Yarnell J, Lowe GD, Rumley A et al (2010) An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension 56(1):36–43PubMedCrossRefGoogle Scholar
  58. Nagai Y, Metter EJ, Earley CJ, Kemper MK, Becker LC, Lakatta EG et al (1998) Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation 98(15):1504–1509PubMedCrossRefGoogle Scholar
  59. Nagasaki T, Inaba M, Kumeda Y, Ueda M, Hiura Y, Tahara H et al (2005) Decrease of arterial stiffness at common carotid artery in hypothyroid patients by normalization of thyroid function. Biomed Pharmacother 59(1–2):8–14PubMedCrossRefGoogle Scholar
  60. Najjar SS, Scuteri A, Lakatta EG (2005) Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 46(3):454–462PubMedCrossRefPubMedCentralGoogle Scholar
  61. Nilsson PM, Boutouyrie P, Laurent S (2009) Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 54(1):3–10PubMedCrossRefPubMedCentralGoogle Scholar
  62. Nilsson PM, Boutouyrie P, Cunha P, Kotsis V, Narkiewicz K, Parati G et al (2013) Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens 31(8):1517–1526PubMedCrossRefPubMedCentralGoogle Scholar
  63. Obuobie K, Smith J, Evans LM, John R, Davies JS, Lazarus JH (2002) Increased central arterial stiffness in hypothyroidism. J Clin Endocrinol Metab 87(10):4662–4666PubMedCrossRefPubMedCentralGoogle Scholar
  64. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340(1):14–22PubMedCrossRefPubMedCentralGoogle Scholar
  65. Orlandi A, Marcellini M, Spagnoli LG (2000) Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 20(4):1123–1136PubMedCrossRefPubMedCentralGoogle Scholar
  66. O’Rourke MF, Safar ME, Dzau V (2010) The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med 15(6):461–468PubMedCrossRefPubMedCentralGoogle Scholar
  67. Palmieri EA, Fazio S, Palmieri V, Lombardi G, Biondi B (2004) Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. Eur J Endocrinol 150(6):757–762PubMedCrossRefPubMedCentralGoogle Scholar
  68. Persy V, D’Haese P (2009) Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 15(9):405–416PubMedCrossRefPubMedCentralGoogle Scholar
  69. Psaty BM, Furberg CD, Kuller LH, Bild DE, Rautaharju PM, Polak JF et al (1999) Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med 159(12):1339–1347PubMedCrossRefGoogle Scholar
  70. Psaty BM, Furberg CD, Kuller LH, Cushman M, Savage PJ, Levine D et al (2001) Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med 161(9):1183–1192PubMedCrossRefPubMedCentralGoogle Scholar
  71. Renier G, Clement I, Desfaits AC, Lambert A (1996) Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production. Endocrinology 137(11):4611–4618PubMedCrossRefPubMedCentralGoogle Scholar
  72. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP et al (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304(12):1365–1374PubMedPubMedCentralCrossRefGoogle Scholar
  73. Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336(8710):285–288PubMedCrossRefPubMedCentralGoogle Scholar
  74. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH (2001) Telomere shortening in atherosclerosis. Lancet 358(9280):472–473PubMedCrossRefPubMedCentralGoogle Scholar
  75. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ et al (2004) Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43(8):1388–1395PubMedCrossRefPubMedCentralGoogle Scholar
  76. Sengstock DM, Vaitkevicius PV, Supiano MA (2005) Arterial stiffness is related to insulin resistance in nondiabetic hypertensive older adults. J Clin Endocrinol Metab 90(5):2823–2827PubMedCrossRefPubMedCentralGoogle Scholar
  77. Serra V, von Zglinicki T, Lorenz M, Saretzki G (2003) Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 278(9):6824–6830PubMedCrossRefPubMedCentralGoogle Scholar
  78. Sharpless NE, DePinho RA (2007) How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8(9):703–713PubMedCrossRefPubMedCentralGoogle Scholar
  79. Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS et al (2004) Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145(6):2804–2814PubMedCrossRefPubMedCentralGoogle Scholar
  80. Shimada T, Takeshita Y, Murohara T, Sasaki K, Egami K, Shintani S et al (2004) Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse. Circulation 110(9):1148–1155PubMedCrossRefPubMedCentralGoogle Scholar
  81. Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF et al (2002) Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clin Endocrinol 56(4):493–501CrossRefGoogle Scholar
  82. Spallarossa P, Brunelli C, Minuto F, Caruso D, Battistini M, Caponnetto S et al (1996) Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol 77(2):200–202PubMedCrossRefPubMedCentralGoogle Scholar
  83. Spyridopoulos I, Isner JM, Losordo DW (2002) Oncogenic ras induces premature senescence in endothelial cells: role of p21(Cip1/Waf1). Basic Res Cardiol 97(2):117–124PubMedCrossRefPubMedCentralGoogle Scholar
  84. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER et al (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 21(2):93–111; quiz 89–90CrossRefGoogle Scholar
  85. Stuijver DJ, van Zaane B, Romualdi E, Brandjes DP, Gerdes VE, Squizzato A (2012) The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: a systematic review and meta-analysis. Thromb Haemost 108(6):1077–1088PubMedPubMedCentralGoogle Scholar
  86. Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y et al (2007) IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 27(12):2684–2690PubMedCrossRefPubMedCentralGoogle Scholar
  87. Takamura N, Akilzhanova A, Hayashida N, Kadota K, Yamasaki H, Usa T et al (2009) Thyroid function is associated with carotid intima-media thickness in euthyroid subjects. Atherosclerosis 204(2):e77–e81PubMedCrossRefPubMedCentralGoogle Scholar
  88. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP (2010) The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification. Curr Opin Cardiol 25(4):394–398PubMedCrossRefPubMedCentralGoogle Scholar
  89. US Census Bureau (2010) 2008 National populations projections., 20 Sept 2010
  90. Van Bortel LM, Laurent S, Boutouyrie P et al (2012) Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 30(3):445–448PubMedCrossRefPubMedCentralGoogle Scholar
  91. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE (2003) Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157(1):25–31PubMedCrossRefPubMedCentralGoogle Scholar
  92. van der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ et al (2007) Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 49(13):1459–1464PubMedCrossRefPubMedCentralGoogle Scholar
  93. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS et al (2001) Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 32(2):454–460PubMedCrossRefPubMedCentralGoogle Scholar
  94. Vasan RS, Sullivan LM, D’Agostino RB, Roubenoff R, Harris T, Sawyer DB et al (2003) Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 139(8):642–648PubMedCrossRefPubMedCentralGoogle Scholar
  95. Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55(13):1318–1327PubMedCrossRefPubMedCentralGoogle Scholar
  96. Volzke H, Robinson DM, Schminke U, Ludemann J, Rettig R, Felix SB et al (2004) Thyroid function and carotid wall thickness. J Clin Endocrinol Metab 89(5):2145–2149PubMedCrossRefPubMedCentralGoogle Scholar
  97. Wang M, Zhang J, Jiang LQ, Spinetti G, Pintus G, Monticone R et al (2007) Proinflammatory profile within the grossly normal aged human aortic wall. Hypertension 50(1):219–227PubMedCrossRefPubMedCentralGoogle Scholar
  98. Wautier JL, Schmidt AM (2004) Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95(3):233–238PubMedCrossRefPubMedCentralGoogle Scholar
  99. Weischer M, Bojesen SE, Cawthon RM, Freiberg JJ, Tybjaerg-Hansen A, Nordestgaard BG (2012) Short telomere length, myocardial infarction, ischemic heart disease, and early death. Arterioscler Thromb Vasc Biol 32(3):822–829PubMedCrossRefPubMedCentralGoogle Scholar
  100. Wenisch C, Myskiw D, Gessl A, Graninger W (1995) Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism. J Clin Endocrinol Metab 80(7):2122–2126PubMedPubMedCentralGoogle Scholar
  101. Willeit P, Willeit J, Brandstatter A, Ehrlenbach S, Mayr A, Gasperi A et al (2010) Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 30(8):1649–1656PubMedCrossRefPubMedCentralGoogle Scholar
  102. Zieman SJ, Melenovsky V, Kass DA (2005) Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25(5):932–943PubMedCrossRefPubMedCentralGoogle Scholar
  103. Zureik M, Temmar M, Adamopoulos C, Bureau JM, Courbon D, Thomas F et al (2002) Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness. J Hypertens 20(1):85–93PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Irina D. Strazhesko
    • 1
    Email author
  • Daria A. Kashtanova
    • 1
  • Ekaterina N. Dudinskaya
    • 1
  • Olga N. Tkacheva
    • 1
  1. 1.Russian Clinical Research Center for GerontologyPirogov Russian National Research Medical UniversityMoscowRussian Federation

Personalised recommendations